Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Canaccord Genuity analyst William Plovanic initiated coverage on Artivion, Inc. AORT with a Buy rating and announced a price target of $35. Artivion shares closed at $28.73 on Monday. See how other analysts view this stock.
- Citigroup analyst Geoff Meacham initiated coverage on Novavax, Inc. NVAX with a Sell rating and announced a price target of $6. Novavax shares closed at $7.03 on Monday. See how other analysts view this stock.
- China Renaissance analyst Cindy Wang initiated coverage on Coinbase Global, Inc. COIN with a Buy rating and announced a price target of $353.3. Coinbase shares closed at $261.57 on Monday. See how other analysts view this stock.
- Jones Trading analyst Debanjana Chatterjee initiated coverage on Theravance Biopharma, Inc. TBPH with a Buy rating and announced a price target of $24. Theravance Biopharma shares closed at $10.75 on Monday. See how other analysts view this stock.
- Johnson Rice analyst Martin Malloy initiated coverage on Venture Global, Inc. VG with a Buy rating and announced a price target of $20. Venture Global shares closed at $17.40 on Monday. See how other analysts view this stock.
Considering buying COIN stock? Here’s what analysts think:
Advertisement
Read This Next:
Photo via Shutterstock
Loading…
Loading…
AORTArtivion Inc
$30.141.48%
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Edge Rankings
Momentum
78.50
Growth
14.19
Quality
Not Available
Value
13.54
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
|
date ▲▼ |
ticker ▲▼ |
name ▲▼ |
Price Target ▲▼ |
Upside/Downside ▲▼ |
Recommendation ▲▼ |
Firm ▲▼ |
|---|
Analyst Calendar
Join Benzinga Edge and unlock all the major upgrades, downgrades, and changes to the market’s most accurate analysts.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Already a member?Sign in